Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "antibodies"

232 News Found

Jackson ImmunoResearch launches new antibodies and conjugates
News | November 26, 2024

Jackson ImmunoResearch launches new antibodies and conjugates

GFP is a common fusion protein tag that enables protein expression to be monitored, quantified, and localized within the complex environment of the cell


Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
News | August 23, 2024

Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target

This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties


Biotium introduces novel antibody labeling Kits for efficient labeling of IgM antibodies
News | June 27, 2023

Biotium introduces novel antibody labeling Kits for efficient labeling of IgM antibodies

Mix-n-Stain CF Dye IgM Antibody Labeling Kits address longstanding challenges for labeling IgM antibodies by offering efficient and convenient conjugation with bright CF Dyes


Biotium introduces new line of antibodies for exosome detection
News | July 18, 2022

Biotium introduces new line of antibodies for exosome detection

ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers


Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest
Biotech | August 13, 2021

Study shows Moderna vaccine maintains antibodies against Variants of Concern and Interest

Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose


Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies
Biotech | August 09, 2021

Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies

Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series


Zydus seeks DCGI approval for monoclonal antibodies cocktail
Policy | May 27, 2021

Zydus seeks DCGI approval for monoclonal antibodies cocktail

Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants


Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics
interviews | April 29, 2026

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies


Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
Biotech | April 29, 2026

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology

The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use


Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
R&D | April 22, 2026

Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies

Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research